Search Results
110 results
Your search is now limited to «Takeda» expert search.
PharmaTimes 03/22/2019 09:14
Takeda has announced the National Institute for Health and Care Excellence (NICE) recommendation of its advanced cutaneous T-cell lymphoma (CTCL) drug Adcetris (brentuximab vedotin.
More from PharmaTimes:
WN.com 03/22/2019 03:40
LegoChem Biosciences entered research collaboration and license agreement with Takeda for antibody-drug conjugates development in immuno-oncology.
More from WN.com:
FiercePharmaManufacturing 03/20/2019 17:30
The FDA has approved a submission from Takeda to produce Flexbumin human albumin solution at the $1 billion plant in Covington, Georgia, that it picked up in its buyout of Shire.
More from FiercePharmaManufacturing:
Contract Pharma 03/20/2019 10:33
HemoShear Therapeutics, LLC has extended its partnership with Takeda Pharmaceutical Co. to discover and develop additional novel therapeutics for liver diseases, including nonalcoholic steatohepatitis (NASH.
More from Contract Pharma:
PR Newswire 03/20/2019 07:30
In addition, the Company has exclusive partnerships to discover novel therapeutic approaches in nonalcoholic steatohepatitis (NASH) with Takeda and in gout with Horizon Pharma.
More from PR Newswire:
Business Wire 03/18/2019 08:00
This latest approval is a significant milestone for the Georgia facility, Takeda and our patients,” said Thomas Wozniewski, Global Manufacturing & Supply Officer.
More from Business Wire:
pharmaphorum 03/12/2019 05:27
A three-drug regimen for multiple myeloma based on Johnson & Johnson’s Darzalex, Takeda’s Velcade and dexamethasone will be made available to patients in England, but only via the Cancer Drugs Fund (CDF.
More from pharmaphorum:
ENDPOINTS 03/11/2019 10:25
Takeda $TAK says their drug Entyvio has beat out AbbVie’s $ABBV Humira in a head-to-head study for ulcerative colitis.
More from ENDPOINTS:
BioPharma Dive 03/11/2019 09:34
On two secondary endpoints, Entyvio showed a higher rate of mucosal healing but AbbVie's therapy showed a numerical edge in the percentage of patients who achieved corticosteroid-free clinical remission, Takeda conceded.
More from BioPharma Dive:
Takeda Pharmaceutical 02/20/2019 01:00
Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience, and Rare Diseases.
More from Takeda Pharmaceutical:
Pharmafile 02/14/2019 07:58
Takeda’s Adcetris (brentuximab vedotin) has seen its marketing authorisation expanded by the European Commission to include the treatment of previously untreated CD30+ Stage IV Hodgkin lymphoma in combination with AVD (Adriamycin, vinblastine and dacarbazine) in adult ...
More from Pharmafile:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications